191R Timely 49483 080 Sennosides 8.6 mg Tablets
- Manufacturer
- TIME CAP LABORATORIES, INC | TIME CAP LABORATORIES, INC.
- Effective date
- 2025-02-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 7
- Source
- full-release
- Hydrated at
- 2026-06-01 00:54:45
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each tablet)
Sennosides 8.6 mg
OTC - PURPOSE SECTION
Purpose
Laxative
INDICATIONS & USAGE SECTION
Uses
- relieves occasional constipation (irregularity)
- generally causes bowel movement in 6-12 hours
WARNINGS SECTION
Warnings
OTC - DO NOT USE SECTION
Do not use
- laxative products for longer than 1 week unless directed by a doctor
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you have
- stomach pain
- nausea
- vomiting
- noticed a sudden change in bowel movements that continues over a period of 2 weeks
OTC - STOP USE SECTION
Stop use and ask a doctor if
you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions
- take preferably at bedtime or as directed by a doctor
- if you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage) or decrease dose until you are comfortable
age
starting dosage maximum dosage adults and children 12 years and over 2 tablets once a day 4 tablets twice a day children 6 to under 12 years 1 tablet once a day 2 tablets twice a day children 2 to under 6 years 1/2 tablet once a day 1 tablet twice a day children under 2 years ask a doctor ask a doctor
OTHER INFORMATION
Other information
- each tablet contains: calcium 25 mg,sodium 2 mg (VERY LOW SODIUM)
- store at 25°C (77°F) excursions permitted between 15°-30°C (59°-86°F)
INACTIVE INGREDIENT SECTION
Inactive ingredients croscarmellose sodium, dibasic calcium phosphate dihydrate, hypromellose, magnesium stearate, microcrystalline cellulose, mineral oil
OTC - QUESTIONS SECTION
Questions or comments?
call 1-877-290-4008
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 763296 | Senna-Time 8.6 MG Oral Tablet | PSN | 7 |
| 312935 | sennosides 8.6 MG Oral Tablet | PSN | 7 |
| 763296 | sennosides, USP 8.6 MG Oral Tablet [Senna-Time] | SBD | 7 |
| 312935 | sennosides, USP 8.6 MG Oral Tablet | SCD | 7 |
| 763296 | Senna-Time 8.6 MG Oral Tablet | SY | 7 |
| 312935 | sennosides A and B 8.6 MG Oral Tablet | SY | 7 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49483-080-00 | 2025-02-10 | C162847 | 48780-1 | 2cef2736-b2cf-d83d-e063-dadaa90ab31f | 191R Timely 49483 080 Sennosides 8.6 mg Tablets |
| 49483-080-01 | 2025-02-10 | C162847 | 48780-1 | 2cef2736-b2cf-d83d-e063-dadaa90ab31f | 191R Timely 49483 080 Sennosides 8.6 mg Tablets |
| 49483-080-10 | 2025-02-10 | C162847 | 48780-1 | 2cef2736-b2cf-d83d-e063-dadaa90ab31f | 191R Timely 49483 080 Sennosides 8.6 mg Tablets |
| 49483-080-00 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-b2cf-d83d-e063-dadaa90ab31f | 191R Timely 49483 080 Sennosides 8.6 mg Tablets |
| 49483-080-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-b2cf-d83d-e063-dadaa90ab31f | 191R Timely 49483 080 Sennosides 8.6 mg Tablets |
| 49483-080-10 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-b2cf-d83d-e063-dadaa90ab31f | 191R Timely 49483 080 Sennosides 8.6 mg Tablets |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49483-080-00 | SENNA TIME | 100000 in 1 CARTON | TABLET, COATED | 100000 | 7 | |
| 49483-080-01 | SENNA TIME | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | 7 | |
| 49483-080-10 | SENNA TIME | 1000 in 1 BOTTLE, PLASTIC | TABLET, COATED | 1000 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49483-080-01 | EA - Each | 49483-080 | 2a975f41-459c-40f7-bd31-b959b44eb14d | 1 | 2012-07-24 |
| 49483-080-10 | EA - Each | 49483-080 | 13d69fcc-a762-4953-9a30-e27716d917a0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| SENNOSIDES A AND B | ACTIVE INGREDIENT | 1B5FPI42EN | 1 | |
| SENNOSIDES A AND B | ACTIVE MOIETY | 1B5FPI42EN | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | 1 | |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | INACTIVE INGREDIENT | O7TSZ97GEP | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 1 |
Products#
Every source-derived product name is available through these pages.
- SENNA TIME
- SENNOSIDES
- DIBASIC CALCIUM PHOSPHATE DIHYDRATE
- HYPROMELLOSES
- MAGNESIUM STEARATE
- MICROCRYSTALLINE CELLULOSE
- MINERAL OIL
- SENNOSIDES A AND B
- CROSCARMELLOSE SODIUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 49483-080 | 49483-080-01, 49483-080-00, 49483-080-10 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| SENNOSIDES A AND B | 1B5FPI42EN | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | TABLET, COATED / ORAL | 488.7 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | TABLET, COATED / ORAL | 488.7 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, COATED / ORAL | 184 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | TABLET, COATED / ORAL | 488.7 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | TABLET, COATED / ORAL | 488.7 mg | ||
| CROSCARMELLOSE SODIUM | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, COATED / ORAL | 224 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SENNA TIME | SENNOSIDES | TIME CAP LABORATORIES, INC | 18ec8127-422c-4c1a-8331-58dabce69969 | 2025-02-08 | Warnings | 49483-080-00 49483-080-01 49483-080-10 49483-080 49483008010 49483008001 49483008000 2d9b792b-a932-6981-e063-6294a90af7ef 18ec8127-422c-4c1a-8331-58dabce69969 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

